Recruiting
Arteriosclerosis
RecruitingStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
Investigational
Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
Investigational
- Disease:Arteriosclerosis
- Substances:Laroprovstat
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Laroprovstat
- Sponsor:AstraZeneca AB



